{
  "scenario_id": "genomics_population_screening_2025",
  "context": "Large health system with 2M covered lives, implementing preventive genomics program",
  "stakeholders": {
    "requester": "Chief Medical Officer",
    "approvers": [
      "CEO",
      "Chief Financial Officer",
      "Board of Directors"
    ],
    "influencers": [
      "Department of Genetics",
      "Ethics Committee",
      "Patient Advocacy Groups",
      "Insurance Partners"
    ]
  },
  "request": {
    "amount": "$25,000,000",
    "purpose": "Implementation of population-level genomic screening for 50,000 high-risk patients",
    "urgency": "medium",
    "justification": "Early detection of genetic predispositions could prevent 30% of targeted diseases and reduce long-term healthcare costs"
  },
  "decision_process": [
    {
      "stage": "clinical_evidence_review",
      "duration": "6 weeks",
      "activities": [
        "Systematic literature review",
        "Cost-effectiveness analysis",
        "Clinical utility assessment"
      ],
      "outcome": "Strong evidence for clinical benefit in targeted populations"
    },
    {
      "stage": "ethical_and_privacy_evaluation",
      "duration": "4 weeks",
      "activities": [
        "Privacy impact assessment",
        "Informed consent framework development",
        "Genetic discrimination risk analysis"
      ],
      "outcome": "Comprehensive privacy protections and ethical guidelines established"
    },
    {
      "stage": "operational_feasibility_study",
      "duration": "8 weeks",
      "activities": [
        "Workflow integration assessment",
        "Staff training requirements",
        "Technology infrastructure evaluation"
      ],
      "outcome": "Feasible implementation with existing EHR integration"
    },
    {
      "stage": "financial_modeling",
      "duration": "4 weeks",
      "activities": [
        "ROI analysis",
        "Budget impact modeling",
        "Reimbursement strategy development"
      ],
      "outcome": "5-year ROI of 3.2x with net present value of $45M"
    }
  ],
  "business_impact": {
    "expected_cost_savings": "$120,000,000",
    "projected_health_outcomes": "Prevention of 15,000 adverse health events",
    "risk_factors": [
      "Patient acceptance and uptake",
      "Data privacy concerns",
      "Clinical false positives",
      "Regulatory changes"
    ],
    "strategic_alignment": "Positions health system as leader in preventive genomic medicine and improves population health metrics"
  }
}